GeM

AOC

Low Competition

Goods

USFDA/DGCI approved third generation Everolimus Drug Eluting Cobalt Chromium Coronary Stent assorte

PRODUCT_CUSTOM

Converts to RA

Custom Item

USFDA/DGCI approved third generation Everolimus Drug Eluting Cobalt Chromium Coronary Stent assorte

Indian Air Force

Kanpur Nagar, Uttar Pradesh

Amount: Refer DocsCloses: 25 May 2026

Corrigendum

Closed

Bids

3 Bids10 Jun 2026

#	Company	Offered Item	Amount	Rank	Status
1	L1₹80,356Qualified Make: SMT Model: Tetrilimus Title: USFDA/DGCI approved third generation Everolimus Drug Eluting Cobalt Chromium Coronary Stent assorte	Make: SMT Model: Tetrilimus Title: USFDA/DGCI approved third generation Everolimus Drug Eluting Cobalt Chromium Coronary Stent assorte	₹80,356	L1	Qualified
2	L2₹82,290.66Qualified Make: SYNERGY Model: SYNERGY XD Title: USFDA/DGCI approved third generation Everolimus Drug Eluting Cobalt Chromium Coronary Stent assorte 545 SHOP NO 2 GURUDWARA ROAD WEST GURU ANGAD NAGAR LAXMI NAGAR EAST DELHI DELHI 110092 UDYAM DL 02 0002399 \| EAST DELHI \| DELHI \| 110092	Make: SYNERGY Model: SYNERGY XD Title: USFDA/DGCI approved third generation Everolimus Drug Eluting Cobalt Chromium Coronary Stent assorte	₹82,290.66	L2	Qualified
3	Disqualified Make: Unbrand Model: USFDA/DGCI approved third generation Everolimus Dr Title: USFDA/DGCI approved third generation Everolimus Drug Eluting Cobalt Chromium Coronary Stent assorte	Make: Unbrand Model: USFDA/DGCI approved third generation Everolimus Dr Title: USFDA/DGCI approved third generation Everolimus Drug Eluting Cobalt Chromium Coronary Stent assorte	-	-	Disqualified

Corrigenda

Corrigendum

3 updatesLatest on 22 May 2026

Updated dates

Bid Submission End25 May 2026

Bid Opening25 May 2026

Tender Value

Refer Docs

EMD Value

Exempted

Closing Date

25 May 2026, 3:00 pmClosed

Work Description

USFDA/DGCI approved third generation Everolimus Drug Eluting Cobalt Chromium Coronary Stent assorte

Tender Information

Tender ID

9272189

Reference Number

GEM/2026/B/7488553

Tender Type

Two Packet Bid

Product Category

USFDA/DGCI approved third generation Everolimus Drug Eluting Cobalt Chromium Coronary Stent assorte

Location

Kanpur Nagar, Uttar Pradesh

Evaluation Method

Total value wise evaluation

Bid Type

PRODUCT_CUSTOM

Source Website

Subscribe to view

Documents Required

8 documents required · 8 mandatory

RequiredExperience Criteria

RequiredPast Performance

RequiredBidder Turnover

RequiredCertificate (Requested in ATC)

RequiredOEM Authorization Certificate

RequiredOEM Annual Turnover

RequiredAdditional Doc 1 (Requested in ATC)

RequiredCompliance of BoQ specification and supporting document

Eligibility Criteria

Experience

3 yrs

Min Turnover

₹31

OEM Turnover

₹2 L

Past Performance

80%

Purchase Preferences

MSE Purchase PreferenceMSE EMD ExemptionStartup Exemption

Items & Quantities

Item	Delivery Location	Qty	Delivery
USFDA/DGCI approved third generation Everolimus Drug Eluting Cobalt Chromium Coronary Stent assorte	KANPUR CITY	2	30 days

Total: 2

Fee & Financial Details

EMD Fee Amount

Exempted

EMD Fee Exemption Allowed

Yes

Important Dates

Last Activity

10 Jun 2026

Published

6 May 2026

Bid Opening

25 May 2026

Documents

Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.

Tender Documents

bid_9272189.pdf

GEM_BID • 0.11 MB

Additional Documents

specification_main_-1_2026-04-29-16-52-55_442d0ef01c9db03be23293d0837d7e22.pdf

GEM_SPEC • 0.32 MB

Cert_fb19e63b-1583-409a-abbe1777461949280_7AFHMEDSTR.docx

GEM_OTHER • 0.01 MB

gtc.pdf

GEM_OTHER • 0.71 MB

Ready to Participate?

Download all tender documents and submit your bid